electroCore, Inc. ECOR
7.18 USD -0.07 (-0.97%)
At closeNov 9, 2026, 4:00 PM EST
7.70 +0.52 +7.19%
After hours · Nov 9, 4:00 PM ET
7.03 Day range 8.04
4.41 52-week range 12.70
- YTD
- +59.91%
- 1 year
- +23.16%
News
globenewswire.com electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum ROCKAWAY, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in…
seekingalpha.com electroCore, Inc. (ECOR) Q3 2026 Earnings Call Transcript electroCore, Inc. (ECOR) Q3 2026 Earnings Call Transcript
zacks.com electroCore, Inc. (ECOR) Reports Q3 Loss, Misses Revenue Estimates electroCore, Inc. (ECOR) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.4 per share a year ago.
marketbeat.com electroCore Q3 Earnings Call Highlights electroCore NASDAQ: ECOR reported record third-quarter sales and a narrower loss, but revised its 2026 revenue outlook as changes to its sales organization took longer than expected to reach the full…
benzinga.com CORRECTION: electroCore Widens FY2026 Sales Guidance from $41.600M to $39.000M-$42.000M vs $41.915M Est electroCore (NASDAQ:ECOR) widens FY2026 sales outlook from $41.600 million to $39.000 million-$42.000 million vs $41.915 million estimate.
benzinga.com electroCore Q3 2026 Earnings Call Transcript electroCore (NASDAQ:ECOR) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com electroCore Raises FY2026 Sales Guidance from $41.600M to $41.642M vs $41.915M Est electroCore (NASDAQ:ECOR) raises FY2026 sales outlook from $41.600 million to $41.642 million vs $41.915 million estimate.
benzinga.com electroCore Q3 EPS $(0.13) Beats $(0.27) Estimate, Sales $9.690M Miss $10.928M Estimate electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 67.5 percent increase over losses of $(0.40)…
globenewswire.com electroCore Announces Third Quarter 2026 Financial Results Third quarter 2026 net sales of $9.7 million, an increase of 12% over $8.7 million in the third quarter of 2025 Net loss of $1.3 million decreased 61% from prior year with Adjusted EBITDA net loss…- benzinga.com electroCore Submits Premarket Notification Seeking Clearance From FDA For Its Quell Wearable Neuromodulation Platform To Treat Chronic Chemotherapy-Induced Peripheral Neuropathy electroCore, Inc. (NASDAQ:ECOR), ("electroCore" or the "Company"), a bioelectronic technology company, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug